DBV Technologies Reports Full Year 2013 Topline Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGNEUX, France, Jan. 30, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of ViaskinĀ®, a new standard in the treatment of allergy, announced today its full year 2013 topline and cash position.

Help employers find you! Check out all the jobs and post your resume.

Back to news